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Abstract. Circulating tumor cells (CTCs) are recognized as a candidate biomarker with strong prognostic and
predictive potential in metastatic disease. Filtration-based enrichment technologies have been used for CTC
characterization, and our group has previously developed a membrane microfilter device that demonstrates
efficacy in model systems and clinical blood samples. However, uneven filtration surfaces make the use of stan-
dard microscopic techniques a difficult task, limiting the performance of automated imaging using commercially
available technologies. Here, we report the use of Fourier ptychographic microscopy (FPM) to tackle this chal-
lenge. Employing this method, we were able to obtain high-resolution color images, including amplitude and
phase, of the microfilter samples over large areas. FPM’s ability to perform digital refocusing on complex images
is particularly useful in this setting as, in contrast to other imaging platforms, we can focus samples on multiple
focal planes within the same frame despite surface unevenness. In model systems, FPM demonstrates high
image quality, efficiency, and consistency in detection of tumor cells when comparing corresponding microfilter
samples to standard microscopy with high correlation (R2 ¼ 0.99932). Based on these results, we believe that
FPM will have important implications for improved, high throughput, filtration-based CTC analysis, and, more
generally, image analysis of uneven surfaces. © The Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported
License. Distribution or reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1
.JBO.19.6.066007]
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1 Introduction
Metastatic disease accounts for 90% of cancer-related mortality,
and is the most important determinant in clinical management of
patients with cancer. As a result, circulating tumor cells (CTCs)
in peripheral blood have emerged in recent years as a valuable
biomarker with strong potential to improve prognosis and diag-
nosis of recurrence. Assaying for CTCs requires only a simple,
minimally invasive blood draw, providing a unique opportunity
for repeated sampling in patients to monitor both metastatic dis-
ease as well as therapeutic response in real time. Thus, the enu-
meration of CTCs with respect to progression-free survival,
overall survival, and therapeutic response has been widely
reported on in a number of solid tumor malignancies.1–6
Currently, isolation of CTCs by density gradient centrifuga-
tion,7,8 indirect detection of CTCs by RT-PCR,9–11 and affinity-
based capture of CTCs using cell surface markers specifically
expressed by malignant cells,1–6,12 are the strategies most com-
monly used to identify and isolate CTCs. However, current strat-
egies for CTC analysis each have limitations.13,14 In addition,
size-based isolation of CTCs from whole blood has been
attempted since 1960s,15 and has been revisited more recently.
Utilizing the well-known characteristic that the malignant cells
are larger than surrounding normal blood cells, CTCs are iso-
lated by using microfilters fabricated with a defined pore
size, which allow for the passage of smaller blood cells to
pass while capturing larger CTCs.15–22 Where the sensitivity
and efficiency of affinity-based CTC enrichment strategies
rely primarily on tissue- and/or tumor-specific cell surface bio-
markers with the potential for highly variable inter tumor
expression, size-based enrichment technologies are “antigen
expression-agnostic,” allowing analysis of CTCs in tumor
types with low or no target antigen expression.
With the potential to overcome the limitations accompanying
other platforms, size-based CTC enrichment strategies possess
technical limitations of their own. The most significant of these
limitations is that following sample processing, the surface of
the microfilters becomes uneven with short, microscale modu-
lations. Because captured cells are randomly dispersed through-
out the microfilter, often times multiple CTCs are present on
different focal planes. This technical limitation requires that
the user must constantly change focus while viewing and imag-
ing cells of interest on the microfilter, making sample analysis
labor intensive, time consuming, and inefficient. Automated im-
aging systems have been developed and are widely available on
a number of microscopy platforms, and could potentially alle-
viate these complications. However, such systems cannot
readily be employed for CTC analysis using filtration-based
technologies due to their inability to focus multiple areas
with different focal planes within the same frame.
Further complicating this issue, when viewing microfilters
under a microscope to identify CTCs, the entire filtration*Address all correspondence to: Richard Cote, E-mail: RCote@med.miami.edu
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area must be viewed by systematically moving up and down the
microfilter in columns (i.e., in y-axis plane), or side to side
across the microfilter in rows (i.e., x-axis plane) manually
using the stage manipulator knobs. In instances where the
observer does not appropriately align adjoining columns and
or rows on the microfilter, small areas where tumor cells
may reside can escape the field of view (FOV) and fail to be
counted, or single events can be counted more than once if
adjoining columns or rows are aligned slightly overlapping
each other. Without the ability to produce images for CTC
analysis in an automated fashion, the potential for inter-operator
variability and inconsistent analyses between users and collabo-
rating institutions reviewing the same samples is dramatically
increased. These technical limitations, taken together, prevent
widespread analysis of CTCs using filtration-based CTC enrich-
ment technologies.
To address these challenges, we present the adaptation of
Fourier ptychographic microscopy (FPM) for the identification
and enumeration of CTCs captured by size-based enrichment.
The use of FPM allows for the rapid generation of continuous,
high-resolution images over large areas of interest. Importantly,
we also describe the ability to perform digital refocusing of
images generated by FPM on a frame-by-frame basis, allowing
us to create focused images of frames containing cells of interest
in multiple focal planes, thus traversing the limitations in auto-
mated imaging of uneven surfaces produced by other commer-
cially available technologies. Here, we present an assessment of
our ability to analyze CTCs captured on a previously described
membrane microfilter device developed by our group using
FPM, evaluating the efficiency of CTC detection as well as
the image quality of CTCs generated by FPM relative to stan-
dard microscopic analysis.
2 Membrane Microfilter Device for Circulating
Tumor Cell Capture and Characterization
Among others,16–20 our group has developed a membrane micro-
filter device for the size-based isolation of CTCs in blood.21,22
Microfilters for CTC capture and analysis are fabricated using a
precisely defined, stepwise photolithography process as previ-
ously described.21 Our technology provides the opportunity
to perform molecular characterization of CTCs beyond their
enumeration, a critical step toward a better understanding of
the mechanisms involved in their release, hematogenous spread,
and colonization of tissues at distant sites from the tumor origin.
Although based on similar principles for CTC enrichment, the
fundamental differences between our technology and other size-
based technologies are (1) the material from which the filters are
manufactured (i.e., parylene-C versus polycarbonate, respec-
tively) and (2) the manner in which the pores are deposited
onto the membrane, where pores are evenly and specifically dis-
persed on our device rather than randomly dispersed.21 We have
evaluated the performance of the microfilter device in model
systems and clinical samples, where in side-by-side comparison
with the CellSearch platform, the microfilter device demon-
strated superior sensitivity in both model systems and clinical
blood samples.22
3 Principles of Fourier Ptychographic
Microscopy
FPM is a method that can capture a wide field-of-view image
with high resolution.23,24 The core principle of FPM is its ability
to acquire high spatial frequency components of the sample by
illuminating it with a plane wave at oblique angles. The FPM
setup consists of the following components: a Olympus BX
41 microscope with 0.08 NA using a Plan APO 2× objective
lens (Olympus, Center Valley, Pennsylvania), a KAI-29050
interline CCD camera with 5.5 μm pixel size (Eastman
Kodak, Rochester, New York) attached to a computer for
image capturing and processing, and a square light-emitting
diode (LED) array for illumination. The LED matrix contains
32 × 32 surface-mounted, full-color LEDs and adjacent LEDs
are laterally separated by 4 mm. The full-color LED has central
wavelengths of 632 nm (red), 532 nm (green), and 472 nm
(blue), each offering a spatially coherent quasimonochromatic
source with ∼20 nm bandwidth. When an LED on the matrix
is activated, its light field incident on the sample can be approxi-
mated as a plane wave due to the large distance (∼8 cm)
between the LED and the sample plane. The angular illumina-
tion can be characterized by its in-plane wavevector ðkx; kyÞ
within the coordinate system, as depicted in Fig. 1.
Illuminating a sample with a plane wave of a wavevector in
the space domain is equivalent to shifting the center of the sam-
ple’s frequency spectrum in the Fourier domain. Because the
objective acts as a circular, low-pass filter in Fourier domain,
each captured image carries information describing a shifted
small subregion, which is geometrically defined by the pupil
function of the microscope, of the sample’s frequency spectrum.
Images are captured by the camera with single LEDs of one
color activated in sequence acting as the light source, and a
phase retrieval algorithm is used to stitch the subregions together
in the Fourier domain to form a high-resolution complex image,
which contains both amplitude and phase information. Red,
green, and blue images are acquired separately by altering
the color of the LED for each set of acquisitions. Single
Fig. 1 (a) The FPM setup consists of (from the bottom) an LEDmatrix
for sample illumination, a microscope system with a 2× objective,
and a camera connected to a computer. (b) The Fourier spectrum
point of view. The center red subregion corresponds to the spatial fre-
quency of the low-resolution image captured with plane waves with
kx ¼ ky ¼ 0. The off-center red subregion correlates to an oblique
angle illumination with wavevector ðkx ; ky Þ. (c) Light from an LED
at an oblique angle corresponds to a plane wave with a k vector
ðkx ; ky Þ.
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color channels are used individually for the entire image captur-
ing and reconstruction process. Thus, the procedure is con-
ducted a total of three times for red, green, and blue channels.
These images are later combined to create a full-color image,
such as the ones shown in Fig. 2. In our hands, each sample
takes ∼3 min to capture and 10 min to reconstruct each of
the three color channels, for a total of 39 min to produce a
color image of the entire field. For sample analysis by the
observer, the complex whole FOV image created by FPM is
refocused and partitioned into a total of ∼300 tiles to be
used for CTC identification on the entire field.
Because of the uneven surface of the microfilter containing
cells of interest, an image taken by a standard microscope suffers
from defocus. As shown in Fig. 2, when some parts in the FOV
are in focus [Figs. 2-(d1-1)], other parts can be blurry [Fig 2-(d1-
2)]. Embedded pupil function recovery FPM (EPRY-FPM), a
new phase retrieval algorithm developed by Ou et al., can auto-
matically correct for this aberration.25 When EPRY-FPM
stitches the subregions in the Fourier domain, it does so by iter-
atively recovering both the Fourier spectrum of the sample and
the pupil function. Because of the pupil function, which contains
the aberration of the lens system and the defocus caused by sur-
face unevenness, the Fourier spectrum of the sample is separated
during the EPRY-FPM process. Performing an inverse Fourier
transformation on the sample’s Fourier spectrum results in
an aberration-free, flattened image of the microfilter. As
shown in Fig. 2-(d1), the defocus is corrected automatically
and the components of the image shown in Figs. 2-(d1-1)
Fig. 2 (a) Full field-of-view color image of the entire microfilter containing captured tumor cells by FPM.
Magnified FPM images (b-d1) selected from different areas of the microfilter show detailed morphology of
tumor cells, where all sections are well in focus because of the automatic EPRY-FPM program. (d2) A
standard microscope (with 40× objective) image shows the corresponding region to (d1), but because of
the uneven surface of the microfilter, subregions (d2-1) and (d2-2) cannot be focused simultaneously.
Also, its field of view is limited when compared to (d2), as seen by the aperture’s outline at the edge of the
image, in contrast to FPM’s wide field-of-view that can provide high-resolution images of the entire micro-
filtration area.
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and 2-(d1-2) are well focused. Because the algorithm also recov-
ers the pupil function, the sample’s depth information can be
obtained and graphed, as shown in Fig. 3(a). The graph
shows the microfilter’s severe surface unevenness, which
requires an imaging device with different focusing levels across
the sample. FPM, with its refocusing capacity of up to 300 μm,
is able to image the entire microfilter in focus. Figures 3(b1) and
3(c1) show two different areas at different depth levels on the
microfilter, with 3(b1) being in focus and 3(c1) being out of
focus. After applying FPMs refocusing algorithm, both areas
are brought sharply in focus, as shown in Figs. 3(b2) and 3(c2).
4 Methods
4.1 Cell Culture
The SKBR-3 breast cancer cell line was obtained commercially
from the American Type Tissue Collection (Manassas,
Virginia), thawed to room temperature, and placed into a T25
culture flask containing McCoy’s 5a culture media (Gibco,
Carlsbad, California) supplemented with 10% fetal bovine
serum (Mediatech, Manassas, Virginia) and 100 units per ml
penicillin-streptomycin (Gibco, Carlsbad, California). At 80%
confluency, the cells were harvested from the culture flask
using 0.25% trypsin-EDTA (Gibco, Carlsbad, California),
washed twice in 1x Hank’s Buffered Salt Solution (HBSS;
Invitrogen, Carlsbad, California) and pelleted by centrifugation
at 500 × g.
4.2 Tumor Cell Counting and Seeding into Normal
Donor Blood
SKBR-3 cell concentration per ml solution was obtained
using the Sceptor 2.0 automated handheld cell counter (EMD
Millipore, Billerica, Massachusetts), and the solution was then
diluted to a final concentration of 1 × 104 tumor cells∕ml. For
experiments testing a higher number of tumor cells (i.e., >15
cells seeded) captured on the microfilter, the actual number of
tumor cells seeded into blood must be carefully determined, as
(a) there is the potential for high variability introduced into ali-
quots prepared by serial dilutions and (b) the process of pipetting
tumor cells into the blood itself can be inconsistent from sample
to sample. To account for potential variability, for each experi-
mental replicate, the aliquot volume (i.e., 50 μl) to be delivered
from the diluted cell solution into the donor blood was placed
onto a hemocytometer and manually counted 10 different
times. From these manual counts, the average number of cells
with standard deviation was calculated to more precisely deter-
mine the “actual” target number of cells to be recovered from
the blood and identified by each respective microscopy technol-
ogy. For two experiments testing the lower limit of tumor cell
capture, to remove the Poisson sampling variability that is
Fig. 3 (a) A microfilter’s surface profile characterized by the pupil function recovered from EPRY-FPM
algorithm. The focal plane of the objective is at 150 μm. Themaximum difference in-depth across the filter
is about 250 μm, which is within FPM’s refocusing capacity of 300 μm. In this case, the captured micro-
filter image is sectioned into 17 × 17 tiles, and EPRY-FPM iteratively characterizes each tile’s defocus
level in its high-resolution image reconstruction process. (b1)-(c2) Small subregions are extracted from
two different surface levels, showing before and after refocusing by EPRY-FPM. (b1) is already very
close to the focal plane, so there is only a minor improvement after refocusing, as in (b2). (c1) is not
in the focal plane and is blurry. (c2) shows the refocused result.
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introduced by serial dilution preparation, tumor cells were man-
ually micropipetted while being viewed under a dissecting micro-
scope and introduced directly into the donor blood samples.
4.3 Tumor Cell Capture by the Microfilter Device
In preparation for filtration, individual microfilters are cut away
from a wafer containing multiple microfilters and placed into an
acrylic housing cassette where each is sandwiched between two
thin slabs of polydimethylsiloxane, and clamped at each end to
form an airtight seal.26 10 ml whole blood samples, collected
into anticoagulant vaccutainer tubes, are diluted 1∶1 in 1× phos-
phate buffered saline (PBS; Invitrogen, Carlsbad, California)
and 1∕10 volume of 10% neutral buffered formalin is added
(NBF; VWR International, Radnor, Pennsylvania) to the diluted
blood for a final volume of 20 ml, at a final concentration of 1%
NBF. Diluted, formalin-fixed blood samples are placed on a
rocker for 10 min at room temperature, and are passed through
the microfilter by a syringe fixed onto a luerlock on top of the
acrylic housing cassette at a constant flow rate of 200 ml∕hr
using a motorized syringe pump. Following filtration, microfil-
ters containing CTCs are disengaged from the filtration cassette
and placed onto a glass microscope slide for downstream
molecular analysis. Our method for CTC identification is a dou-
ble marker immunohistochemistry (IHC) protocol (described
later in Sec. 4.4) that includes a pan-cytokeratin (CK) antibody
for identification of epithelial tumor cells and a CD45 antibody
for simultaneous positive selection of tumor cells and negative
selection of large, and tumor blood cells, respectively. The entire
6 × 6 mm area of the microfilter is viewed under a microscope,
and CTCs are identified as large (typically 15–40 μm diameter),
nucleated, CK+/CD45- events with morphological criteria con-
sistent with malignant cells.
4.4 Immunohistochemistry on Tumor Cells Captured
by the Microfilter Device
Following cell seeding and filtration, the microfilters were
placed into 24-well culture dishes to facilitate simultaneous
immunolabeling of multiple microfilters (instead of glass micro-
scope slides) and washed for 10 min in 1x tris buffered saline
(TBS; Biocare Medical, Concord, California). The filters were
rehydrated with washes in decreasing concentrations of alcohol
(100%, 90%, and 70%) for 6 min each wash. To quench any
endogenous perioxidase activity, the microfilters were washed
in 0.03% H2O2 + methanol for 20 min. Following the periox-
idase quench, the microfilters were washed with deionized H2O,
and nonspecific reactivity with primary antibodies was blocked
with buffer containing 5% normal goat serum, 1% BSA, and
0.3% Triton X-100 in 1x TBS for 30 min. Rabbit antihuman
CK (1∶300; DAKO, Carpinteria, California) and mouse antihu-
man CD45 (Ready-to-use; DAKO, Carpinteria, California) were
cocktailed together and incubated with the microfilters over-
night at room temperature. The microfilters were washed in
1x TBS for 10 min, and then incubated with MACH 2 secondary
antibody buffer (Biocare Medical, Concord, California), con-
taining both conjugated goat antirabbit alkaline phosphatase
(AP) and goat antimouse horseradish perioxidase (HRP) activ-
ity, for 30 min. Microfilters were washed in 1x TBS for 10 min,
then incubated with 3’, 3’-diaminobenzidine (DAB; Biocare
Medical, Concord, California), reactive with HRP, for 5 min
to form a brown precipitate reporting antiCD45 reactivity.
Microfilters were washed in deionized H2O, and then incubated
with Warp Red (Biocare Medical, Concord, California), reactive
with AP, for 7 min to form a red precipitate reporting antiPan
CK reactivity. Microfilters were washed with deionized H2O,
incubated with CAT hematoxylin (Biocare Medical, Concord,
California) 3 min for nuclear visualization, Tacha’s Bluing
Reagent (Biocare Medical, Concord, California) for 3 min,
dehydrated with increasing concentrations of alcohol (70%,
90%, and 100%), washed with xylene, and coverslipped
using mounting medium (Richard Allan Scientific, Waltham,
Massachusetts). To verify antibody specificity, cytospin slides
were prepared using a mixture of SKBR-3 and peripheral
blood mononuclear cells (1∶4), enriched by gradient-based cen-
trifugation from a normal donor, and used as positive controls.
5 Circulating Tumor Cell Analysis Using
Fourier Ptychographic Microscopy Versus
Standard Microscopy in Model Systems
SKBR-3 breast cancer cells were seeded into 5 ml of whole
blood from a normal, healthy donor at various concentrations,
processed by the microfilter device, and labeled with CK and
CK45 by double marker IHC on glass microscope slides. A
total of 11 replicates of this experiment were performed. Nine
normal donor blood samples were seeded with a range of tumor
cells (15 to ∼800), representing the lower and upper limits of
CTCs typically identified from clinical blood samples using
the microfilter device. As a negative control, two normal
donor blood samples containing no tumor cells were processed
by the microfilter device and analyzed microscopically using
both technologies. In all samples tested, captured tumor cells
were enumerated first by “standard microscopy”—Axio
Imager M1 with an Apochromat 20 × ∕0.8 NA objective lens
(Carl Zeiss Microscopy LLC, Thornwood, New York) and
the tumor cell counts were compared to enumeration done by
FPM in corresponding samples.
Table 1 demonstrates the comparison of tumor cells identi-
fied by both microscopy technologies among corresponding
samples captured by the microfilter device. The primary objec-
tive of this comparison was to evaluate the ability of FPM versus
our standard method of microscopy to produce high-resolution
images that can be used to accurately and efficiently detect
tumor cells captured by the microfilter device. No tumor
cells were detected in the negative control samples by either
technology (Table 1), indicating that the images produced by
FPM were suitable for the identification of specific biomarker
reactivity and evaluation of morphologic criteria, both important
parameters used to differentiate tumor cells from nucleated,
tumor blood cells. Tumor cell identification rates on microfilters
by standard microscopy (85.7% 6.68%; Table 1) are consis-
tent with recovery rates previously reported using our CTC
enrichment system in model system experiments,21,22 and are
also consistent with tumor cell identification rates in corre-
sponding microfilter samples evaluated by FPM (88.8%
8.3%; Table 1). Further, a Pearson’s correlation between cells
identified by both technologies on corresponding microfilter
samples was conducted to evaluate the consistency of tumor
cell identification by FPM relative to standard microscopy.
As demonstrated in Fig. 4, the R2 for tumor cells identified
in corresponding microfilter samples was 0.99932, indicating
a strong correlation between tumor cells counted by both tech-
nologies. This further demonstrates FPM as a suitable imaging
method that provides comparable accuracy in tumor cell detec-
tion and enumeration to standard microscopy.
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6 Discussion
The primary aim of this paper is to evaluate whether the FPM
can provide images that are suitable for CTC counting with
comparable accuracy to a skilled microscopist operating a stan-
dard microscope. The near equivalence in accuracy that we
found here is assuring and positive. As described earlier, we
have highlighted the potential for errors in under or over count-
ing CTCs on microfilters using standard microscopy. In con-
trast, FPM produces continuously tiled images composed of
the entire filtration area with no significant error. Thus, the
risk for missing or over counting small regions of view between
rows or columns of the filtration area is removed by FPM. In the
hands of a less skilled user, we can expect better counting accu-
racy for the FPM versus the standard microscope. Finally, it is
worth noting that the examination of the slide under the standard
microscope is laborious and highly manual. Digitization of the
slide by FPM can allow for CTC counting in a more comfortable
setting for the user in the near term, and allow for automatic
counting in the future when appropriate algorithms have been
developed.
As conventional whole slide imaging (WSI) systems allow
for slide digitization as well, it is definitely worth discussing
the relative merits of the FPM versus the conventional WSI
scanning methods. Some of the advantages held by the FPM
include simplified and robust system design due to the nonme-
chanical scanning approach, and the potential advantage in scan
speed as the scan method is entirely optical. However, the
strongest advantage that FPM has over conventional WSI sys-
tems for imaging the microfilters lies in the fact that FPM’s refo-
cusing ability is very well suited to tackle the uneven nature of
the microfilters. While certain conventional WSI systems are
able to dynamically adjust their focal plane as they scan micro-
scope slides, the focal plane at any given FOV through their
objective is still fixed. As we can see from the standard micros-
copy images demonstrated in Figs. 2-(d2-1) and 2-(d2-2), only
portions of the microfilter can be focused at any one time,
despite the use of a 40X objective lens with a restrictive
FOV. As shown, the FPM can nimbly adjust its focal plane,
so that all parts of the sample are in focus.
Following this line of thought, we can also imagine that one
of the ways conventional WSI systems can match this FPM ad-
vantage would be to exhaustively collect a z-stack of images at
Table 1 Table comparing detection of tumor cells seeded into normal donor blood by FPM and standard microscopy.
Tumor cells seeded
Tumor cell count by
standard microscopy
Tumor cell count
by FPM % Recovery by standard microscopy % Recovery by FPM
804  64 684 718 85.1% (78.8%–92.4%) 89.3% (82.0%–97.0%)++
582 45 538 541 92.5% (85.8%–100%) 92.9% (86.2%–100%)++
812 72 765 788 94.2% (86.5%–100%) 97.0% (89.1%–100%)++
128  14 99 108 77.3% (69.7%–86.8%) 84.3% (76.1%-94.7%)++
617 68 560 584 90.7% (81.8%–100%) 94.7% (85.3%–100%)++
*10 6 7 60% 70%++
61  8 48 62 78.7% (69.6%–90.6%) 100% (89.9%–100%)++
55  10 42 38 76.4% (64.6%–93.3%)+ 69.1% (58.4%–84.6%)
*15 14 11 93.30%+ 73.30%
0 0 0 0% 0%
0 0 0 0% 0%
Note: % recovered = (tumor cell count by FPM or standard microscopy/tumor cells seeded) × 100%. For each count observed, the upper and lower
limits, as defined by the standard deviation in the number of cells seeded, are included in parentheses. % Recovery values labeled with “+” indicate
trials where % recovery by standard microscopy > % recovery by FPM. % Recovery values labeled with “++” indicate trials where % recovery by
standard microscopy <% recovery by FPM. Rows labeled with an asterisk indicate trials where tumor cells were micropipetted under observation
with a dissecting microscope and directly introduced into normal donor blood, and thus have no standard error caused by serial dilution preparation.
Fig. 4 Graph demonstrating the correlation between tumor cell count
by standard microscopy (y -axis) and tumor cell count by FPM (x -axis)
in corresponding microfilter samples, where each data point repre-
sents a single trial with tumor cells enumerated by both methods.
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z-increments equal to the depth of field of the native objective.
The data can be provided to the user to pick the right focal plane
to examine each part of microfilter as desired. However, the data
size associated with such an imaging method would be very sig-
nificant. Using our current experiment microfilter as an example
(desired FOV of 6-mm diameter, resolution of 0.78 μm, objec-
tive’s depth of field of ∼5 μm, and a total sample height varia-
tion of 250 μm), the total amount of data that a conventional
WSI system would have to collect for a color image would
be equal to ∼8.9 gigapixels, one-third of which is assigned
to each of the RGB channels. In comparison, the FPM would
have to collect ∼1.4 gigapixels worth of data for a color
image and titrate that to a final image that contains
∼360 megapixels that can be refocused within a depth of
field of 300 μm. Additionally, each FPM image pixel contains
both amplitude and phase information, while a standardWSI file
is strictly an intensity (amplitude) map.
A potential advantage for the continued use of standard
microscopy for the identification and molecular characterization
of CTCs is the ability to perform immunofluorescent (IF) analy-
ses using the microfilter. The use of secondary antibodies con-
jugated to specific fluorophores with narrow and intense spectra
profiles enables the performance of downstream techniques,
such as fluorescent in situ hybridization (FISH) and multimarker
characterization of CTCs by IF. The FPM system used in this
study is only functional for the conjugation of antibodies to sec-
ondary chromagens in the visible spectrum by brightfield
microscopy. However, the FPM system can be readily modified
to provide low-resolution fluorescence imaging capability. We
simply have to insert an appropriate filter into the system and
incorporate a sufficiently bright excitation light source. The res-
olution of such fluorescence images would be determined by the
objective employed by the FPM. If the current FPM system was
modified for fluorescence imaging, the fluorescence image res-
olution will be equal to ∼4 μm. At this resolution, the modified
FPM would be able to identify which cells are fluorescing.
Future studies using the FPM for CTC analysis will make
attempts to provide low-resolution fluorescence imaging
capability, which could potentiate the ability to view multiple
fluorescently labeled biomarkers on CTCs in a multiplexed
fashion.
7 Conclusion
Ours and several other groups have demonstrated size-based
isolation by microfiltration to be a promising and efficient
method for CTC enrichment. However, technical issues associ-
ated with postenrichment analysis using these technologies
present limitations that could hinder advances in molecular
characterization of CTCs and widespread use. Herein, we
present FPM as a means to overcome these technical barriers,
producing continuous, high resolution, and automated images of
the entire filtration area. Where other automated imaging sys-
tems are limited, the ability of FPM to perform digital refocus-
ing of each image by a phase-retrieval algorithm is a critical
innovation of our system. Beyond the identification and charac-
terization of CTCs using filtration-based technologies, FPM
holds the potential for use in many other biomedical applica-
tions, such as immunohistochemistry in histology and cytology,
as well as others that can benefit from a high resolution, wide
FOV digital imaging technique with an automatic aberration
correction.
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